These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 31634150
21. 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease. Li XH, Dai CF, Chen L, Zhou WT, Han HL, Dong ZF. CNS Neurosci Ther; 2016 Jul; 22(7):617-24. PubMed ID: 27079181 [Abstract] [Full Text] [Related]
22. Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function. Ciron C, Lengacher S, Dusonchet J, Aebischer P, Schneider BL. Hum Mol Genet; 2012 Apr 15; 21(8):1861-76. PubMed ID: 22246294 [Abstract] [Full Text] [Related]
23. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T. J Pharmacol Exp Ther; 2007 Jul 15; 322(1):274-81. PubMed ID: 17429058 [Abstract] [Full Text] [Related]
29. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Kupsch A, Sautter J, Schwarz J, Riederer P, Gerlach M, Oertel WH. Brain Res; 1996 Nov 25; 741(1-2):185-96. PubMed ID: 9001722 [Abstract] [Full Text] [Related]
30. PGC-1α Promoter Methylation in Parkinson's Disease. Su X, Chu Y, Kordower JH, Li B, Cao H, Huang L, Nishida M, Song L, Wang D, Federoff HJ. PLoS One; 2015 Nov 25; 10(8):e0134087. PubMed ID: 26317511 [Abstract] [Full Text] [Related]
32. Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization. Eschbach J, von Einem B, Müller K, Bayer H, Scheffold A, Morrison BE, Rudolph KL, Thal DR, Witting A, Weydt P, Otto M, Fauler M, Liss B, McLean PJ, Spada AR, Ludolph AC, Weishaupt JH, Danzer KM. Ann Neurol; 2015 Jan 25; 77(1):15-32. PubMed ID: 25363075 [Abstract] [Full Text] [Related]
33. Folic Acid Rescues Dopaminergic Neurons in MPTP-Induced Mice by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment. Jia Y, Li J, Wang Y, Ma Y, Chen L, Zhang H, Xue M, Liang H. J Agric Food Chem; 2024 Mar 20; 72(11):5734-5745. PubMed ID: 38453725 [Abstract] [Full Text] [Related]
36. Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease. Joniec-Maciejak I, Wawer A, Turzyńska D, Sobolewska A, Maciejak P, Szyndler J, Mirowska-Guzel D, Płaźnik A. Pharmacol Rep; 2018 Oct 20; 70(5):988-992. PubMed ID: 30107349 [Abstract] [Full Text] [Related]
37. Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson's disease model of mice. Haeri P, Mohammadipour A, Heidari Z, Ebrahimzadeh-Bideskan A. Anat Sci Int; 2019 Jan 20; 94(1):119-127. PubMed ID: 30159851 [Abstract] [Full Text] [Related]
38. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice. Hong Z, Wang G, Gu J, Pan J, Bai L, Zhang S, Chen SD. Eur J Neurosci; 2007 Sep 20; 26(6):1500-8. PubMed ID: 17714494 [Abstract] [Full Text] [Related]